{"id":"NCT01157078","sponsor":"AstraZeneca","briefTitle":"A Study to Assess the Efficacy and Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder (MDD)","officialTitle":"A Multicenter, Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Phase III Efficacy and Safety Study of TC-5214 (S-mecamylamine) in Flexible Doses as an Adjunct to an Antidepressant in Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Therapy","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-06","primaryCompletion":"2011-11","completion":"2011-11","firstPosted":"2010-07-05","resultsPosted":"2012-11-20","lastUpdate":"2014-04-11"},"enrollment":319,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Major Depressive Disorder","Depression"],"interventions":[{"type":"DRUG","name":"TC-5214","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"TC-5214","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to determine if TC-5214 or placebo (a tablet that looks like medicine tablet or capsule, but contains no active medicine) is safe and effective when taken together with another antidepressant.","primaryOutcome":{"measure":"Change in the Montgomery-Asberg Depression Rating Scale (MADRS) Total Score From Randomization to End of Treatment.","timeFrame":"Randomization (Week 8) to end of treatment (Week 16)","effectByArm":[{"arm":"TC-5214","deltaMin":-12.7,"sd":0.8},{"arm":"Placebo","deltaMin":-11.7,"sd":0.8}],"pValues":[{"comp":"OG000 vs OG001","p":"0.349"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":3},"locations":{"siteCount":51,"countries":["United States","India"]},"refs":{"pmids":["24507016"],"seeAlso":["http://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_6111&studyid=333&filename=CSR-D4130C00002.pdf","http://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_7111&studyid=333&filename=D4130C00002_Revised_CSP_2_REDACTED.PDF"]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":157},"commonTop":["Headache","Constipation","Diarrhoea","Dizziness","Nausea"]}}